Does valve system reduce the catheter-related bloodstream infection?
The GC has no superiority over the conventional AC for preventing CVC-RBSI.
These findings suggest for the first time that low levels of JAM-A expression in pancreatic cancer are associated with poor clinical outcome. JAM-A may represents a target molecule for functional inactivation and serve as a novel biomarker of adverse prognosis in pancreatic cancer.